|
|
|
Insider
Information: |
Carey Robert |
Relationship: |
Director |
City: |
Deerfield |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
3,076,937 |
|
Indirect Shares
|
249,091 |
|
|
Direct
Value |
$528,186 |
|
|
Indirect Value
|
$7,049,275 |
|
|
Total
Shares |
3,326,028 |
|
|
Total
Value |
$7,577,461 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Horizon Pharma, Inc. |
HZNP |
EVP, Chief Business Of... |
2019-03-23 |
17,267 |
2019-03-23 |
249,091 |
Premium* |
|
Argos Therapeutics Inc |
ARGS |
Director |
2016-12-31 |
8,206 |
2016-03-31 |
0 |
Premium* |
|
Sangamo Biosciences Inc |
SGMO |
|
2024-06-04 |
74,600 |
2018-06-11 |
0 |
Premium* |
|
Beyond Air Ord Shs |
XAIR |
Director |
2024-03-20 |
2,976,864 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
67 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XAIR |
Beyond Air Ord Shs |
Director |
|
2022-11-16 |
4 |
B |
$6.00 |
$60,000 |
D/D |
10,000 |
752,323 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2022-11-17 |
4 |
B |
$5.90 |
$118,000 |
D/D |
20,000 |
772,323 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2022-11-18 |
4 |
B |
$5.80 |
$116,000 |
D/D |
20,000 |
792,323 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2022-11-28 |
4 |
B |
$5.75 |
$86,243 |
D/D |
15,000 |
807,323 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2022-11-29 |
4 |
B |
$5.75 |
$86,249 |
D/D |
15,000 |
822,323 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2022-12-07 |
4 |
B |
$5.75 |
$115,000 |
D/D |
20,000 |
842,323 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2023-03-08 |
4 |
B |
$5.95 |
$59,500 |
D/D |
10,000 |
852,323 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2023-03-29 |
4 |
B |
$6.30 |
$63,000 |
D/D |
10,000 |
876,496 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2023-03-30 |
4 |
B |
$6.45 |
$64,500 |
D/D |
10,000 |
886,496 |
2.39 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Director |
|
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,900 |
49,600 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2023-08-18 |
4 |
B |
$2.64 |
$35,940 |
D/D |
13,614 |
900,110 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2023-08-21 |
4 |
B |
$2.76 |
$207,453 |
D/D |
75,050 |
975,160 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2023-08-28 |
4 |
B |
$2.70 |
$673,750 |
D/D |
250,000 |
1,225,160 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2023-12-18 |
4 |
B |
$1.64 |
$1,962,000 |
D/D |
1,200,000 |
2,374,454 |
2.39 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2024-03-20 |
4 |
A |
$1.66 |
$1,000,001 |
D/D |
602,410 |
2,976,864 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
|
|
2024-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
74,600 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP & Chief Business OfficerOf |
|
2014-03-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
57,655 |
|
- |
|
67 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|